IV Lidocaine for Tinnitus
Study Summary
This trial is testing whether IV lidocaine can help doctors understand which brain networks are involved in tinnitus, by temporarily suppressing the tinnitus and observing changes in brain function.
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Are there any available opportunities for individuals to partake in this research?
"Data from clinicaltrials.gov confirms that this medical study is still searching for participants, with its initial posting on April 28th 2021 and most recent amendment occurring on August 26th 2022."
Have there been other investigations regarding intravenous lidocaine?
"Presently, there are 119 trials for intravenous lidocaine in progress with 31 experiments in the third phase. Calgary, Alberta hosts a few of these studies but you can find over one thousand other sites that are running clinical tests as well."
What purposes is IV Lidocaine typically employed to serve?
"Intravenous lidocaine is a popular method for treating cervical syndrome, as well as minor burns, organ transplantation, and osteoporosis."
How many people are actively engaging in this research endeavor?
"Affirmative. The information hosted on clinicaltrials.gov suggests that this trial is currently enrolling participants. This clinical research was first published April 28th 2021 and last modified August 26th 2022, with a total of 40 patients across a single location being sought out for enrolment."